ALS (motor neurone disease) trials in Russia

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

  Where

  Moscow, Novosibirsk

  Age

  18 years to 81 years

  People

  495 worldwide

  Run by

  AB Science

  See details and how to joinNCT03127267